28.5 C
New York
Thursday, June 18, 2026

Tag: presentation

Star Equity Holdings, Inc. Announces 2025 Second Quarter Financial Results

Q2 2025 revenues increased ~76% to $23.7 million and gross profit increased ~182% to $6.3 million

Mesa Air Group Reports Third Quarter Fiscal 2025 Results and Provides Update on Proposed Merger with Republic Airways Holdings Inc.

Management to Hold Call Following Market Close Today
Management to Hold Call Following Market Close Today

RADCOM Delivers 19% YoY Revenue Growth and Margin Expansion in the Second Quarter of 2025

Continued Growth and Improved Profitability Reinforce Full-Year Outlook TEL AVIV, Israel, Aug. 13, 2025 /PRNewswire/ -- RADCOM Ltd (Nasdaq: RDCM) announced today its financial results for...

NACCO INDUSTRIES TO PARTICIPATE IN THE 16th ANNUAL MIDWEST IDEAS INVESTOR CONFERENCE

CLEVELAND, Aug. 13, 2025 /PRNewswire/ -- NACCO Industries® (NYSE:NC) announced today that the Company will participate in the 16th Annual Midwest Ideas Investor Conference...

China Automotive Systems Reports Income From Operations Increased by 20.2% in the Second Quarter of 2025

WUHAN, China, Aug. 13, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in...

Invitation to Paratus’ Q2 2025 Earnings Call

HAMILTON, Bermuda, Aug. 13, 2025 /PRNewswire/ -- Paratus Energy Services Ltd. (ticker "PLSV") ("Paratus" or the "Company") will release its unaudited interim Q2 and Half-year...

AB Akola Group will hold an Investor Webinar to introduce the financial results for the 12 months of financial year 2024/2025

AB Akola Group, company code: 148030011, address of the head office: Subaciaus str. 5, LT-01302 Vilnius, Lithuania.

Invitation to Paratus’ Q2 2025 Earnings Call

HAMILTON, Bermuda, Aug. 13, 2025 /PRNewswire/ -- Paratus Energy Services Ltd. (ticker "PLSV") ("Paratus" or the "Company") will release its unaudited interim Q2 and Half-year...

Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity

Greywolf starts first trial of GRWD0715, aiming for a functional cure for autoimmunity by targeting its antigenic source.

First six months 2025: solid results and continued strategy delivery, highlighted by the launch of 313.7 MW Kelmė wind farm, the largest in the...

AB “Ignitis grupė” publishes its First six months 2025 interim report, which is attached to this notice.

First six months 2025: solid results and continued strategy delivery, highlighted by the launch of 313.7 MW Kelmė wind farm, the largest in the...

AB “Ignitis grupė” publishes its First six months 2025 interim report, which is attached to this notice.

Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye

Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone) in Türkiye for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.

Wong To Yick Wood Lock Medicated Balm Proudly Announces Cantopop Diva Joey Yung as Its First-Ever Brand Ambassador

"No.1 Meets No.1" – A Legendary Collaboration Redefining Excellence HONG KONG, Aug. 13, 2025 /PRNewswire/ -- Renowned Hong Kong heritage brand Wong To Yick Wood...

MEREN ANNOUNCES SECOND QUARTER 2025 RESULTS AND DECLARES THIRD QUARTERLY DIVIDEND

VANCOUVER, BC, Aug. 12, 2025 /CNW/ - (TSX: MER) (Nasdaq-Stockholm: MER) – Meren Energy Inc. ("Meren" or the "Company") today published its financial and operating...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPresentation